CJC-1295 with DAC
Also known as: CJC-1295 DAC, Drug Affinity Complex
Molecular Identifiers
Overview
Long-acting GH secretagogue. Provides sustained GH elevation through albumin conjugation (DAC), extending the half-life to 6-8 days. Frequently combined with Ipamorelin for synergistic effect.
YADAIFTQSYRKVLAQLSARKLLQDILSR Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg Half-life
~6-8 days
Administration Route
Subcutaneous
Category
GH Secretagogues
Mechanism of Action
- GHRH receptor agonist in the anterior pituitary
- Albumin conjugation via Drug Affinity Complex extends half-life
- Sustained stimulation of GH secretion for 6-8 days
- Elevation of serum IGF-1
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 1-2 mg per week |
| Frequency | Once per week |
| Timing | Before bedtime |
| Duration | 8-12 weeks minimum |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Facial flushing
- Water retention
- Tingling
- Headache
- Drowsiness
Presentations & Preparation
Vials of CJC-1295 with DAC found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 2 ml per 5 mg vial
- Inject the diluent slowly against the vial wall
- Gently swirl until fully dissolved
- Never shake
Storage
- Lyophilized: Room temperature or -20°C (up to 24 months)
- Reconstituted: Refrigerated 2-8°C (up to 30 days)
- Protect from direct light
- Do not freeze after reconstitution
Scientific Studies
Published studies on CJC-1295 with DAC.
Safety and tolerability of long-acting release recombinant human growth hormone-releasing hormone in adults with growth hormone deficiency
Ionescu M, Frohman LA
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
Related Peptides
CJC-1295 sem DAC
100-200 mcg per injection · 2-3 times daily
GHRP-2
100-300 mcg per injection · 2-3 times per day
GHRP-6
100-300 mcg per injection · 2-3 times per day
Hexarelin
200-300 mcg per injection · 2-3 times per day
Ipamorelin
200-300 mcg per injection · 2-3 times daily
MK-677
10-25 mg per dose · Once daily